Catalyst Wire Dossier Catalyst Wire Dossier

LYN-005

· Lyndra Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LYN-005, covering 2024-10-24 to 2024-10-24. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Pharmacokinetics (PK) and Safety/Tolerability of Long-Acting Oral LYN-005 [Phase 3]

See pricing